Relationship between hypophyseal portal GHRH and somatostatin and peripheral GH levels in the conscious sheep
- 6 Downloads
The mechanisms involved in the genesis of pulsatile GH secretion are not well understood. Recently, methods for hypophyseal portal blood collection in conscious sheep became available. Using this method, GHRH and SRIH secretion into hypophyseal portal blood (HPB) and GH release from the pituitary gland were simultaneous assessed and the relationship between GHRH and SRIH changes in HPB and GH in peripheral blood was investigated. In 23 rams (9–11 month old, 35–45 kg bw), 126 hours of HPB were analysed. Fifty-four spontaneous GH peaks were detected. The majority of GH peaks (48.1%) was associated with an increased portal GHRH and a fall in somatostatin concentrations. A simultaneous increase in GHRH and somatostatin levels was observed in 18.5% of GH peaks while 12.9% of peaks occurred with a fall in SRIH and no modification in GHRH concentrations. Finally, 5/54 (9.3%) GH peaks occurred without any modification in portal GHRH and SRIH release. Our data indicate that the GHRH/SRIH interplay is complex. The occurrence of spontaneous GH peaks may be due not only to a coordinate increase in GHRH and reduction in SRIH release similar to male rat, but also to other patterns of GHRH/SRIH secretion.
Key-wordsGHRH somatostatin GH secretion hypophyseal portal blood
Unable to display preview. Download preview PDF.
- 4.Isgaard J., Carlsson L., Isaksson O.G., Jansson J.O. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology 123: 2605, 1988.PubMedCrossRefGoogle Scholar
- 15.Frohman L.A., Downs T.R., Clarke I.J., Thomas G.B. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia. J. Clin. Invest. 86: 17, 1990.PubMedCentralPubMedCrossRefGoogle Scholar
- 16.Thomas G.B., Cummins J.T., Francis H., Sudbury A.W., Mc Cloud P.I., Clarke I.J. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes. Endocrinology 128: 1151, 1991.PubMedCrossRefGoogle Scholar
- 18.Locatelli A., Caraty A. Approche transnasale du systeme porte hypophysaire chez le bélier: application à l’étude des neurosécrétions. Sci. Tech. Anim. Lab. 12: 185, 1987.Google Scholar
- 23.Jaffe C.A., De Mott Friberg R., Barkan A.L. Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GH-RH) antagonist. Direct evidence for involvement of endogenous GH-RH in the generation of GH pulses. J. Clin. Invest. 92: 695, 1993.PubMedCentralPubMedCrossRefGoogle Scholar
- 27.Magnan E., Cataldi M., Guillaume V., Conte-Devolx B., Graziani N., Figaroli J.C., Thomas F., Chihara K., Oliver C. Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long acting somatostatin analog, in rams. Life Sci 51: 831, 1992.PubMedCrossRefGoogle Scholar
- 28.Epelbaum J., Moyse E., Tannenbaum G.S., Kordon C., Beaudet A. Combined autoradiographic and immunohistochemical evidence for an association of somatostatin binding sites with growth hormone-releasing factor-containing nerve cell bodies in the rat arcuate nucleus. J. Neuroendocrinol. 1: 109, 1989.PubMedCrossRefGoogle Scholar